Daavlin LUMERA Targeted Phototherapy System - HSA Registration DE0012558
Access comprehensive regulatory information for Daavlin LUMERA Targeted Phototherapy System in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0012558 and owned by Daavlin Distributing Company. The device was registered on March 12, 2013.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Lumera Phototherapy System is intended for use in UVB Phototherapy for the treatment of psoriasis, including scalp psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leucoderma. The Lumera Phototherapy System is intended for use on all skin types (I-VI).

